{"summary": "the development of drug-resistant TB during the treatment increases the treatment complexity. the long-term pulmonary complications after completing treatment raise the epidemic health burden. a total of 3925 TB patients were categorized as: CM users for respiratory discomforts (n = 2051) and non-CM users (n = 1874). CM is popular among patients with a medical history of TB complicated with long-term respiratory discomforts in Taiwan. further pharmacological investigations and clinical trials are required."}